GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Ventana Biotech Inc (OTCPK:VNTA) » Definitions » Gross-Profit-to-Asset %

Ventana Biotech (Ventana Biotech) Gross-Profit-to-Asset % : 0.00% (As of . 20)


View and export this data going back to 2008. Start your Free Trial

What is Ventana Biotech Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Ventana Biotech's annualized Gross Profit for the quarter that ended in . 20 was $ Mil. Ventana Biotech's average Total Assets over the quarter that ended in . 20 was $ 0 Mil. Therefore, Ventana Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

Ventana Biotech Gross-Profit-to-Asset % Historical Data

The historical data trend for Ventana Biotech's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ventana Biotech Gross-Profit-to-Asset % Chart

Ventana Biotech Annual Data
Trend
Gross-Profit-to-Asset %

Ventana Biotech Semi-Annual Data
Gross-Profit-to-Asset %

Competitive Comparison of Ventana Biotech's Gross-Profit-to-Asset %

For the Shell Companies subindustry, Ventana Biotech's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ventana Biotech's Gross-Profit-to-Asset % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Ventana Biotech's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Ventana Biotech's Gross-Profit-to-Asset % falls into.


Ventana Biotech Gross-Profit-to-Asset % Calculation

Ventana Biotech's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Ventana Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Ventana Biotech Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Ventana Biotech's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ventana Biotech (Ventana Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Ventana Biotech Inc (OTCPK:VNTA) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
EMAX LSMG FBDS PCMC FSTJ KATX TRXA HGYN ATYG RMHI PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA
Traded in Other Exchanges
N/A
Address
1660 South Albion Street, Suite 1007, Denver, CO, USA, 80222
Website
https://www.launchpadcafe.net
Ventana Biotech Inc is a development stage company providing alternative financing in the capacity of a broker for those commercial borrowers in need of non-bank financing.